Structure-Based Optimization of Pyrazinamide-Containing Macrocyclic Derivatives as Fms-like Tyrosine Kinase 3 (FLT3) Inhibitors to Overcome Clinical Mutations.
基于结构的吡嗪酰胺类大环衍生物优化作为 Fms 样酪氨酸激酶 3 (FLT3) 抑制剂以克服临床突变
期刊:ACS Pharmacology and Translational Science
影响因子:3.7
doi:10.1021/acsptsci.4c00071
Zheng Xuan, Chen Zhiwen, Guo Ming, Liang Hong, Song Xiaojuan, Liu Yiling, Liao Zhenling, Zhang Yan, Guo Jing, Zhou Yang, Zhang Zhi-Min, Tu Zhengchao, Zhang Ye, Chen Yongheng, Zhang Zhang, Lu Xiaoyun
